Milenko Cicmil
Gründer bei Tasca Therapeutics Corp.
Profil
Milenko Cicmil is the founder of Tasca Therapeutics Corp.
He is currently a Venture Partner at Cure Ventures Management LP.
Dr. Cicmil previously worked as a Director at Merck & Co., Inc. and as a Vice President at Ipsen SA. He also held the position of Vice President at Fog Pharmaceuticals, Inc. Dr. Cicmil obtained a doctorate degree from The University of Reading in 2000 and an undergraduate degree from King's College London in 1997.
Aktive Positionen von Milenko Cicmil
| Unternehmen | Position | Beginn |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.07.2021 |
Tasca Therapeutics Corp.
 Tasca Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Tasca Therapeutics Corp. develops molecule drugs. The American company was founded by Milenko Cicmil, David E. Fisher, Duojia Pan, Xu Wu. Milenko Cicmil has been the CEO since incorporation. | Gründer | - |
Ehemalige bekannte Positionen von Milenko Cicmil
| Unternehmen | Position | Ende |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 31.07.2021 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Milenko Cicmil
| The University of Reading | Doctorate Degree |
| King's College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| IPSEN | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Tasca Therapeutics Corp.
Tasca Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Tasca Therapeutics Corp. develops molecule drugs. The American company was founded by Milenko Cicmil, David E. Fisher, Duojia Pan, Xu Wu. Milenko Cicmil has been the CEO since incorporation. | Health Technology |
